[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) – Form 144 filing

Insider Michael Y. Chi has filed a notice to sell 26,350 Class A shares through Fidelity Brokerage on or about 31 Jul 2025 on the NYSE. At the 07/30/25 market price used by the filer, the stake is valued at $1.77 million and represents roughly 0.012 % of the company’s 215.45 million shares outstanding.

The shares were acquired via four employee option grants dated 24 Feb 2022, 27 May 2021, 10 Aug 2022 and 01 Mar 2023, all exercised for cash on 31 Jul 2025. Over the past three months Chi has already disposed of 43,452 shares in five open-market transactions between 06 Jun 2025 and 24 Jul 2025, generating $2.51 million in gross proceeds.

No additional financial data, earnings guidance or company commentary is included in this notice. The filing merely discloses the planned sale under Rule 144 and affirms that the filer is not in possession of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR insider plans another modest sale—routine but adds to recent disposals.

The proposed 26.3k-share sale equates to just 0.012 % of shares outstanding, so the immediate dilution impact is negligible. However, adding this to the 43.5k shares already sold since June lifts Chi’s 3-month liquidation to nearly 70 k shares worth about $4.3 M. While Rule 144 filings are common, concentrated selling in a short window can be interpreted as waning insider conviction. There is no indication of a 10b5-1 plan in the disclosure. Overall market impact should be limited given HIMS’ average daily volume, but traders may view the ongoing sales as a short-term overhang.

Corporate Governance Expert

TL;DR standard Rule 144 notice; pattern of insider sales worth monitoring.

Form 144 fulfills regulatory requirements and signals transparency. The shares stem from option exercises, a typical liquidity event after vesting. That said, the clustering of sales within three months could raise governance questions about alignment with long-term shareholder interests. No adverse information certification mitigates concerns, yet the absence of a disclosed 10b5-1 plan may invite scrutiny if selling persists.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	26350	1765450.00	215453899	07/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/31/2025	Options Granted - 02/24/2022	Issuer			14700	07/31/2025	Cash
Class A	07/31/2025	Options Granted - 05/27/2021	Issuer			3600	07/31/2025	Cash
Class A	07/31/2025	Options Granted - 08/10/2022	Issuer			6300	07/31/2025	Cash
Class A	07/31/2025	Options Granted - 03/01/2023	Issuer			1750	07/31/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/06/2025	5100	285600.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/10/2025	5400	307800.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	17102	1021844.50
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/23/2025	13750	770000.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/24/2025	2100	120792.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares does Michael Y. Chi plan to sell under this Form 144?

He intends to sell 26,350 Class A shares with an estimated market value of $1.77 million.

What percentage of Hims & Hers Health’s shares does the proposed sale represent?

Approximately 0.012 % of the company’s 215.45 million shares outstanding.

When is the approximate sale date for the shares disclosed in the Form 144?

The filing lists an approximate sale date of 31 July 2025.

How many HIMS shares has the insider sold in the past three months?

Chi sold 43,452 shares between 6 June 2025 and 24 July 2025, generating $2.51 million.

Were the shares being sold acquired through option exercises?

Yes. The shares were acquired via four employee option grants from 2021-2023 and exercised for cash on 31 Jul 2025.